Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI
· Real-Time Price · USD
14.71
0.25 (1.73%)
At close: Aug 15, 2025, 3:59 PM
14.60
-0.71%
After-hours: Aug 15, 2025, 07:56 PM EDT
Denali Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 141.21M | 56.95M | 174.96M | 90.64M | 74.68M | 60.57M | 127.11M | 148.01M | 131.97M | 68.13M | 218.04M | 118.61M | 155.09M | 104.95M | 293.48M | 394.55M | 485.68M | 435.32M |
Short-Term Investments | 757.75M | 760.98M | 657.37M | 745.92M | 821.37M | 876.29M | 907.4M | 961.25M | 1.06B | 1.22B | 1.12B | 987.44M | 913.58M | 852.57M | 571.93M | 644.62M | 823.25M | 977.83M |
Long-Term Investments | n/a | 235.84M | 359.37M | 445.46M | 452.59M | 492.32M | 1.6M | 7.91M | 1.6M | 1.5M | 1.5M | 1.5M | 94.22M | 250.27M | 425.45M | 319.47M | 92.52M | 38.88M |
Other Long-Term Assets | 101.43M | 26.93M | 24.74M | 26.49M | 48.98M | 43.02M | 16.54M | 11.14M | 12.83M | 12.52M | 11.9M | 14.62M | 15.18M | 14.21M | 11.87M | 3.78M | 3.58M | 3.74M |
Receivables | n/a | n/a | 2.17M | n/a | n/a | 1.9M | 3.42M | n/a | n/a | 3.2M | 9.28M | n/a | 357K | n/a | 1.23M | 1.19M | 16.79M | 2.51M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.4M | -3.2M | -5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 35.75M | 60.71M | n/a | 32.28M | 32.34M | 1.9M | n/a | 33.63M | 33.08M | 3.2M | n/a | 32.47M | n/a | 30.91M | n/a | n/a | n/a | n/a |
Total Current Assets | 934.71M | 878.64M | 864.44M | 868.84M | 928.38M | 973.58M | 1.06B | 1.14B | 1.22B | 1.33B | 1.37B | 1.14B | 1.11B | 988.44M | 897.23M | 1.06B | 1.34B | 1.43B |
Property-Plant & Equipment | 130.1M | 129.93M | 125.63M | 113.22M | 72.61M | 72.17M | 71.64M | 74.85M | 67.24M | 70.17M | 74.52M | 72.96M | 68.46M | 67.94M | 69.61M | 71.21M | 71.97M | 73.61M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 231.53M | 392.7M | 509.74M | 585.17M | 574.18M | 607.52M | 89.78M | 93.89M | 81.67M | 84.18M | 87.92M | 89.08M | 177.86M | 332.42M | 506.93M | 394.46M | 168.07M | 116.24M |
Total Assets | 1.17B | 1.27B | 1.37B | 1.45B | 1.5B | 1.58B | 1.15B | 1.24B | 1.31B | 1.41B | 1.46B | 1.23B | 1.29B | 1.32B | 1.4B | 1.45B | 1.51B | 1.55B |
Account Payables | 10.84M | 8.46M | 11.14M | 9.59M | 13.94M | 11.86M | 9.48M | 1.18M | 8.52M | 2.21M | 2.79M | 7.54M | 7.12M | 3.36M | 4.78M | 4.82M | 4.24M | 1.63M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 845K | 289.76M | 290.05M | 290.54M | 290.42M | 290.63M | 320.3M | 4.76M | 9.19M | 16.45M |
Short-Term Debt | 8.87M | n/a | n/a | 8.04M | 7.77M | n/a | n/a | 7.01M | 6.77M | n/a | n/a | 7.07M | 5.87M | 5.66M | n/a | 5.25M | 5.05M | 4.88M |
Other Current Liabilities | 82.19M | 24.99M | 54.31M | 54.59M | 35.5M | 12.5M | n/a | 39.63M | 36.19M | 85.2M | 46.67M | 33.76M | 30.56M | 30.09M | 28.7M | 23.63M | 21.58M | 38.27M |
Total Current Liabilities | 91.06M | 91.88M | 102.21M | 87.09M | 74.53M | 82.58M | 77.98M | 71.18M | 69.36M | 391.08M | 363.92M | 360.67M | 348.16M | 341.24M | 378.25M | 54.25M | 51.41M | 54.61M |
Long-Term Debt | 37.69M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 10.44M | 16.73M | 5.62M | 3.94M | n/a | n/a | n/a | 379K | 379K | 379K | 379K | 379K | 379K | 379K | 379K | 701K | 701K | 701K |
Total Long-Term Liabilities | 48.13M | 56.78M | 42.29M | 48.42M | 40.98M | 43.03M | 44.98M | 47.27M | 49.55M | 51.56M | 53.89M | 55.63M | 59.85M | 61.69M | 63.63M | 383.44M | 385.7M | 387.89M |
Total Liabilities | 139.19M | 148.66M | 144.5M | 135.52M | 115.51M | 125.62M | 122.96M | 118.45M | 118.91M | 442.64M | 417.81M | 416.3M | 408.01M | 402.93M | 441.87M | 437.69M | 437.11M | 442.5M |
Total Debt | 46.56M | 48.63M | 48.71M | 52.52M | 48.75M | 50.55M | 52.24M | 53.9M | 55.52M | 57.09M | 60.35M | 62.05M | 61.4M | 62.74M | 58.55M | 65.24M | 66.45M | 67.79M |
Common Stock | 1.78M | 1.78M | 1.77M | 1.76M | 1.76M | 1.75M | 1.71M | 1.71M | 1.7M | 1.69M | 1.69M | 1.56M | 1.56M | 1.55M | 1.55M | 1.54M | 1.54M | 1.54M |
Retained Earnings | -1.8B | -1.67B | -1.54B | -1.42B | -1.32B | -1.22B | -1.12B | -996.74M | -897.38M | -1.08B | -970.99M | -872.31M | -769.01M | -710.22M | -645M | -569.74M | -485.15M | -424.46M |
Comprehensive Income | 939K | 2.04M | 2.02M | 5.53M | -2.66M | -1.3M | 643K | -651K | -1.44M | -2.52M | -6.89M | -11.85M | -12.27M | -9.25M | -2.5M | -521K | -368K | -232K |
Shareholders Equity | 1.03B | 1.12B | 1.23B | 1.32B | 1.39B | 1.46B | 1.03B | 1.12B | 1.19B | 966.71M | 1.04B | 811.3M | 884.45M | 917.93M | 962.29M | 1.01B | 1.07B | 1.11B |
Total Investments | n/a | 996.82M | 1.02B | 1.19B | 1.27B | 1.37B | 909M | 969.15M | 1.06B | 1.22B | 1.12B | 987.44M | 1.01B | 1.1B | 997.38M | 964.09M | 915.77M | 1.02B |